{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:51:44Z","timestamp":1791525104664,"version":"4.3.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Tuberculosis remains a major cause of infectious mortality worldwide, highlighting the need for complementary therapeutic strategies beyond conventional antibiotics. Host-directed approaches may enhance macrophage-mediated control of infection. In this study, we investigated the effects of \u03b2-glucan priming combined with drug-loaded yeast-derived \u03b2-glucan particles (DYDGP) in an\n                    <jats:italic>in vitro<\/jats:italic>\n                    macrophage model of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    infection. Phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 macrophages were compared across unprimed, \u03b2-glucan-only, antibiotic-only, and \u03b2-glucan-primed\/DYDGP-treated groups. \u03b2-Glucan priming combined with DYDGP treatment was associated with enhanced receptor-mediated phagocytic activity, improved intracellular bacterial control, and preserved macrophage integrity. These effects were associated with increased intracellular reactive oxygen species (ROS) production, enhanced phagolysosomal maturation, and altered autophagic activity. Colony-forming unit (CFU) analysis showed that \u03b2-glucan-primed macrophages treated with DYDGP exhibited a significantly lower bacterial burden than the unprimed, \u03b2-glucan-only, and antibiotic-only groups at 1, 6, and 24\u202fh post-infection. Unprimed macrophages showed progressive bacterial growth, with log CFU values of 4.2, 4.8, and 5.2, whereas \u03b2-glucan-primed\/DYDGP-treated macrophages showed reduced values of 3.3, 2.5, and 2.1, respectively. \u03b2-Glucan-only treatment resulted in log CFU values of 4.2, 4.4, and 4.7, while antibiotic-only treatment resulted in values of 4.2, 4.1, and 3.9 at the corresponding time points. These findings suggest that \u03b2-glucan priming combined with DYDGP treatment may enhance intracellular control of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    in this macrophage model and support further investigation of this approach as a potential adjunctive strategy for tuberculosis.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1952695","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:42Z","timestamp":1791523842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-Glucan\u2013mediated macrophage priming enhances macrophage activation and host defense against Mycobacterium tuberculosis infection"],"prefix":"10.3389","volume":"17","author":[{"given":"Firoz","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Physiological Sciences, Oklahoma Centre for Respiratory and Infectious Diseases, Oklahoma State University","place":["Stillwater, OK, United States"]},{"name":"Department of Biosciences, Integral University","place":["Lucknow, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Khubaib","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University","place":["Lucknow, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolee","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Life Sciences & Biotechnology, CSJM University","place":["Kanpur, Uttar Pradesh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"136520","DOI":"10.1016\/j.ijbiomac.2024.136520","article-title":"\u0392-Glucan signalling stimulates NOX-2 dependent autophagy and LC-3 associated autophagy (LAP) pathway","volume":"282","author":"Ahmad","year":"","journal-title":"Int. J. Biol. Macromol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"16437","DOI":"10.1038\/s41598-024-66634-5","article-title":"Rifabutin loaded inhalable \u03b2-glucan microparticle based drug delivery system for pulmonary TB","volume":"14","author":"Ahmad","year":"","journal-title":"Sci. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"137256","DOI":"10.1016\/j.ijbiomac.2024.137256","article-title":"Treatment of Mycobacterium tuberculosis infected macrophages with Rifabutin loaded \u03b2-glucan microparticles induces macroautophagy mediated bacillary killing","volume":"283","author":"Ahmad","year":"","journal-title":"Int. J. Biol. Macromol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO'S global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.micpath.2011.06.006","article-title":"\u0392-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages","volume":"51","author":"Betz","year":"2011","journal-title":"Microb. Pathog."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1159\/000533873","article-title":"Selected \u03b2-glucans act as immune-training agents by improving anti-mycobacterial activity in human macrophages: a pilot study","volume":"15","author":"Braian","year":"2023","journal-title":"J. Innate Immun."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1004485","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1021\/acs.molpharmaceut.5b00831","article-title":"Peptide- and amine-modified glucan particles for the delivery of therapeutic siRNA","volume":"13","author":"Cohen","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"118851","DOI":"10.1016\/j.lfs.2020.118851","article-title":"Particulate \u03b2-glucan activates early and delayed phagosomal maturation and autophagy within macrophage in a NOX-2 dependent manner","volume":"266","author":"Fatima","year":"2021","journal-title":"Life Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"151951","DOI":"10.1016\/j.imbio.2020.151951","article-title":"Natural and trained innate immunity against Mycobacterium tuberculosis","volume":"225","author":"Ferluga","year":"2020","journal-title":"Immunobiology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","article-title":"Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages","volume":"119","author":"Gutierrez","year":"2004","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1046\/j.1365-3083.1998.00350.x","article-title":"Protective effect of beta-glucan against Mycobacterium bovis, BCG infection in BALB\/c mice","volume":"47","author":"Hetland","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1574-695X.2002.tb00570.x","article-title":"Beta-1,3-glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures","volume":"33","author":"Hetland","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"109030","DOI":"10.1016\/j.isci.2024.109030","article-title":"Recognition of yeast \u03b2-glucan particles triggers immunometabolic signaling required for trained immunity","volume":"27","author":"Horneck Johnston","year":"2024","journal-title":"iScience."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1172\/JCI97508","article-title":"Mycobacterial growth inhibition is associated with trained innate immunity","volume":"128","author":"Joosten","year":"2018","journal-title":"J. Clin. Invest."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.cmi.2019.02.015","article-title":"Trained innate immunity and resistance to Mycobacterium tuberculosis infection","volume":"25","author":"Koeken","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"106686","DOI":"10.1016\/j.jddst.2025.106686","article-title":"MPPD modeling based differential lung dosimetry of rifabutin loaded \u03b2-glucan dry powder microparticles in adult mice and various human age groups","author":"Kumar","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0149167","DOI":"10.1371\/journal.pone.0149167","article-title":"Treatment of Mycobacterium tuberculosis-infected macrophages with poly (lactic-co-glycolic acid) microparticles drives NF-\u03baB and autophagy dependent bacillary killing","volume":"11","author":"Lawlor","year":"2016","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s10753-020-01211-2","article-title":"Oat-derived beta glucans induced trained immunity through metabolic reprogramming","volume":"43","author":"Pan","year":"2020","journal-title":"Inflammation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.7150\/thno.64874","article-title":"\u0392-Glucan-coupled superparamagnetic iron oxide nanoparticles induce trained immunity to protect mice against sepsis","volume":"12","author":"Pan","year":"2022","journal-title":"Theranostics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1074\/jbc.M115.699645","article-title":"Fungal chitininduces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae","volume":"291","author":"Rizzetto","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e59414","DOI":"10.1371\/journal.pone.0059414","article-title":"The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks","volume":"8","author":"Sirgel","year":"2013","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"143524","DOI":"10.1155\/2012\/143524","article-title":"Glucan particles for macrophage targeted delivery of nanoparticles","volume":"2012","author":"Soto","year":"2012","journal-title":"J Drug Deliv"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/polym2040681","article-title":"Glucan particle encapsulated rifampicin for targeted delivery to macrophages","volume":"2","author":"Soto","year":"2010","journal-title":"Polymers"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/BJ20110352","article-title":"Glucan particles for selective delivery of siRNA to phagocytic cells in mice","volume":"436","author":"Tesz","year":"2011","journal-title":"Biochem. J."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/infdis\/jiz147","article-title":"Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses","volume":"221","author":"Verrall","year":"2020","journal-title":"J. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1952695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:43Z","timestamp":1791523843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1952695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":31,"alternative-id":["10.3389\/fmicb.2026.1952695"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1952695","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1952695"}}